Bid document

SUBJECT*

Filgrastim Biosimilar (VA-27-00012533)

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*

60141

SOLICITATION NUMBER*

36E79727R0001

RESPONSE DATE/TIME/ZONE

12-15-2026 2:30 PM CENTRAL TIME, CHICAGO, USA

ARCHIVE

99 DAYS AFTER THE RESPONSE DATE

SET-ASIDE

PRODUCT SERVICE CODE*

6505

NAICS CODE*

325412

PLACE OF PERFORMANCE

POSTAL CODE

COUNTRY

CONTACT INFORMATION

CONTRACTING OFFICE ADDRESS

Department of Veterans Affairs
OPAL/National Acquisition Center
Building 37
1st Avenue, One Block North of Cermak

POINT OF CONTACT*

Contract Specialist
Dov Vysnia
[email protected]
708-786-5145

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

[email protected]

EMAIL DESCRIPTION

Agency POC Email

DESCRIPTION

PRE-SOLICITATION NOTICE: The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79727R0001 for an unrestricted procurement for Filgrastim or Biosimilar Syringes, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH2)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs. One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor’s label. All units identified in the Schedule of Supplies (Line Items 1 and 2, 300 mcg and 480 mcg syringes) shall be non-safety syringes. Each syringe shall be indicated and labeled for patient or caregiver use. Offerors must make all commercial packages available (i.e.1 Syringe,1 Box of (10) Syringes). Solicitation # 36E79727R0001 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 01, 2026, with a tentative closing date of December 15, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Dov Vysnia. Questions can be e-mailed to [email protected].